|
health and beauty |
|
|
|
family and relationships |
|
|
|
business and money |
|
|
|
general topics |
|
|
|
|
intrauterine growth retardation Alternative Nameslow birth weight, small for gestational age, dysmaturity, intrauterine growth restriction
Definition
Intrauterine growth retardation, or IUGR, is a condition in which a fetus grows at
a slower rate than expected.
What is going on in the body?
There are expected ranges of growth for a fetus at a given gestational age. The
growth of a fetus depends on the health and nutrition of the mother and the
health of the fetus. IUGR may occur if the health of the placenta or its blood
supply is impaired. IUGR may also occur if the mother's nutrition, health, or
lifestyle prevents a healthy pregnancy.
What are the signs and symptoms of the disease?
There are often no symptoms of IUGR. Symptoms that do occur may include the following:
- a uterus that is smaller than in previous pregnancies
- fewer fetal movements than expected
What are the causes and risks of the disease?
Women with certain conditions may be more likely to have a child with IUGR.
These conditions include the following:
What can be done to prevent the disease?
Most cases of IUGR cannot be prevented, especially if they are due to genetic
causes. Some cases can be prevented by taking the following precautions:
How is the disease diagnosed?
The diagnosis can be made with 2 tests:
pregnancy ultrasound and the nonstress
test. Ultrasound uses many measurements to evaluate expected fetal
growth. The nonstress test measures the heart rate and the
movement of the fetus. Other tests can be used to check for other conditions
affecting the fetus.
What are the long-term effects of the disease?
Long-term effects in the fetus before or during delivery include the following:
- premature delivery
- poor tolerance of labor
- increased chances of a C-section,
or delivery of the baby through an incision in the mother's abdomen
- increased risk of birth defects
- asphyxia, or too little oxygen, at birth, which may lead to cerebral palsy
Long-term effects in the infant after delivery include the following:
- temperature instability
- hypoglycemia, or low blood
sugar
- difficulty fighting infection
- death
Complications later in childhood may include:
What are the risks to others?
IUGR is not contagious, but it does pose a risk for the fetus. IUGR may also
occur in future pregnancies.
What are the treatments for the disease?
Treatment of IUGR depends on the suspected cause and may include the following:
- stopping smoking
- stopping all drugs, such as cocaine and
alcohol
- eating a good diet with proper amounts of
folic acid and other vitamins
- increasing bed rest, lying on the left side as much as possible
- if prescribed, taking low-dose aspirin to prevent tiny clots from
forming in the placenta
- monitoring fetal movements, contractions, or spontaneous rupture of
membranes
- close monitoring by the healthcare provider
- using continuous internal fetal heart
monitoring during labor to detect fetal distress
- using minimal anesthesia, although
epidurals are safe
- having a C-section or forceps
delivery if fetal distress is detected
What are the side effects of the treatments?
Treatments are intended to prevent serious complications in infants with IUGR.
Side effects of surgery include bleeding, infection, and allergic reaction to
anesthesia.
What happens after treatment for the disease?
Recovery from surgery may take a few days to several weeks, depending on the
procedure used. The baby may be given
oxygen, antibiotics, and
intravenous fluids after delivery. An infant with cerebral palsy or
seizures may need physical
therapy. Other disabilities may require other treatments.
How is the disease monitored?
The following may be used to monitor the pregnancy:
- nonstress testing every week or
two
- biophysical profile every week
or two. This test uses ultrasound and a series of measurements to determine
the health status of the developing fetus.
- pregnancy ultrasounds every 10 to
14 days
Any new or worsening symptoms should be reported to the healthcare provider.
| Author: Eva Martin, MD Date Written: 07/19/99 Reviewer: Eileen McLaughlin, RN, BSN Date Reviewed: 07/05/01
Potential conflict of interest information for reviewers available on request
|
|